CRF receptor antagonists
    1.
    发明授权
    CRF receptor antagonists 失效
    CRF受体拮抗剂

    公开(公告)号:US07329667B2

    公开(公告)日:2008-02-12

    申请号:US10476441

    申请日:2002-04-30

    IPC分类号: A01N43/54 C07D239/00

    CPC分类号: C07D471/06 C07D487/06

    摘要: The present invention relates to tricyclic pyrimidines compounds of formula (I) including stereoisomers, prodrugs and pharmaceutically acceptable salts or solvates thereof, to processes for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of conditions mediated by corticotropin-releasing factor (CRF).

    摘要翻译: 本发明涉及式(I)的三环嘧啶化合物,其包括立体异构体,其前药和药学上可接受的盐或溶剂化物,其制备方法,含有它们的药物组合物及其用于治疗由促肾上腺皮质激素释放介导的病症 因子(CRF)。